HPV vaccine is effective at reducing the risk of cervical cancer. The updated vaccine is approved for individuals aged 6 months and older. Health care providers are encouraged to recommend the RSV vaccine to eligible patients. Dr. Ferguson discusses the importance of routine vaccination in children, along with barriers to vaccination. Vaccinated patients had significantly lower rates of postacute sequelae of SARS-CoV-2 at 1 year after infection. COVID-19 vaccination may be associated with a small, transitory effect on uterine bleeding. Vaccines have been developed that significantly reduce the incidence of cervical cancer. There is no significant increase in preterm birth risk associated with COVID-19 vaccination.